By Metro US
Posted on
LONDON (Reuters) – Britain could approve Novavax’s COVID-19 vaccine next month, the chief investigator for the shot’s trial told the Evening Standard newspaper.
“The regulator will do a very detailed and thorough review and will decide in good time,” said Professor Paul Heath, chief investigator for the Novavax jab trial in the UK.
“I would hope it would be in the spring, possibly end of April.”
(Reporting by Guy Faulconbridge; Editing by Kate Holton)
Sixers in need of some home cooking in Game 3 against Knicks
LSU’s Jayden Daniels downplays issues with Commanders, says he’d be ‘blessed’ to go No. 2 overall
Liverpool’s Premier League title hopes hit by 2-0 loss to Everton
Lions agree to contract extensions with St. Brown and Sewell worth combined $200M, AP source says
Mbappe nets twice in 4-1 win over Lorient to put PSG on the verge of French league title
Columbia University protests: House Speaker Mike Johnson visits campus, calls for Shafik’s resignation amidst Pro-Palestine protest encampment
Another ex-State Department official alleges Israeli military gets ‘special treatment’ on abuses
Biden meets 4-year-old Abigail Edan, an American who was held hostage by Hamas
Hamas releases video showing well-known Israeli-American hostage
Pennsylvania redesigned its mail-in ballot envelopes amid litigation. Some voters still tripped up
More cows are being tested and tracked for bird flu. Here’s what that means
More doctors can prescribe a leading addiction treatment. Why aren’t more people getting help?
Missouri House backs legal shield for weedkiller maker facing thousands of cancer-related lawsuits
Dairy cattle must be tested for bird flu before moving between states, agriculture officials say
